Dual inhibition of HERs and PD-1 counteract resistance in KRASG12C-mutant head and neck cancer.
Novoplansky O, Jagadeeshan S, Prasad M, Yegodayev KM, Marripati D, Shareb RA, Greenshpan Y, Mathukkada S, Ben-Lulu T, Bhattacharya B, Porgador A, Kong D, Brägelmann J, Gutkind JS, Elkabets M.
Novoplansky O, et al. Among authors: prasad m.
J Exp Clin Cancer Res. 2024 Nov 20;43(1):308. doi: 10.1186/s13046-024-03227-0.
J Exp Clin Cancer Res. 2024.
PMID: 39567998
Free PMC article.